Leisure-time physical activities and the risk of cardiovascular mortality in the Malmö diet and Cancer study.

Cardiovascular mortality High-intensity physical activity Leisure-time physical activity Prevention Running

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
26 10 2021
Historique:
received: 19 04 2021
accepted: 11 10 2021
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

The association between leisure-time physical activity and cardiovascular mortality has been previously studied, but few studies have focused on specific activities and intensities. The association between different leisure-time physical activities and cardiovascular mortality was investigated among 25,876 individuals without diabetes or cardiovascular disease from the population-based Malmö Diet and Cancer Study cohort. The individuals estimated the average duration spent on 17 physical activities at baseline in 1991-1996 and after 5 years. Cardiovascular mortality was obtained from a register during a mean of 20 years of follow-up. A total leisure-time physical activity of 15-25 metabolic equivalent task (MET) hours/week was associated with a decreased risk of cardiovascular mortality (HR 15-25 vs < 7.5 MET-h/week =0.80, 95% CI 0.69-0.93), with no further risk reduction at higher levels. Several high-intensity activities (i.e., lawn tennis and running) and moderate-intensity activities (i.e., golf, cycling and gardening) were associated with a reduced risk. Individuals who engaged in high-intensity physical activity for an average of 2.29 MET h/week (30 min/week) had an 18% (95% CI 0.72-0.93) reduced risk of cardiovascular mortality compared with non-participants, and no further risk reductions were observed at higher levels. Decreased risk was observed among individuals who had started (HR 0.56, 95% CI 0.32-0.97) or continued (HR 0.49, 95% CI 0.36-0.66) high-intensity activities at the five-year follow-up. Moderate- and high-intensity leisure-time physical activities reduced the risk of cardiovascular mortality. With regard to total leisure-time physical activity, the largest risk reduction was observed for 15-25 MET-h/week (equivalent to walking for approximately 5 h/week).

Sections du résumé

BACKGROUND
The association between leisure-time physical activity and cardiovascular mortality has been previously studied, but few studies have focused on specific activities and intensities.
METHODS
The association between different leisure-time physical activities and cardiovascular mortality was investigated among 25,876 individuals without diabetes or cardiovascular disease from the population-based Malmö Diet and Cancer Study cohort. The individuals estimated the average duration spent on 17 physical activities at baseline in 1991-1996 and after 5 years. Cardiovascular mortality was obtained from a register during a mean of 20 years of follow-up.
RESULTS
A total leisure-time physical activity of 15-25 metabolic equivalent task (MET) hours/week was associated with a decreased risk of cardiovascular mortality (HR 15-25 vs < 7.5 MET-h/week =0.80, 95% CI 0.69-0.93), with no further risk reduction at higher levels. Several high-intensity activities (i.e., lawn tennis and running) and moderate-intensity activities (i.e., golf, cycling and gardening) were associated with a reduced risk. Individuals who engaged in high-intensity physical activity for an average of 2.29 MET h/week (30 min/week) had an 18% (95% CI 0.72-0.93) reduced risk of cardiovascular mortality compared with non-participants, and no further risk reductions were observed at higher levels. Decreased risk was observed among individuals who had started (HR 0.56, 95% CI 0.32-0.97) or continued (HR 0.49, 95% CI 0.36-0.66) high-intensity activities at the five-year follow-up.
CONCLUSIONS
Moderate- and high-intensity leisure-time physical activities reduced the risk of cardiovascular mortality. With regard to total leisure-time physical activity, the largest risk reduction was observed for 15-25 MET-h/week (equivalent to walking for approximately 5 h/week).

Identifiants

pubmed: 34702239
doi: 10.1186/s12889-021-11972-6
pii: 10.1186/s12889-021-11972-6
pmc: PMC8549319
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1948

Informations de copyright

© 2021. The Author(s).

Références

Prev Med. 2008 Sep;47(3):319-23
pubmed: 18455785
NCHS Data Brief. 2017 Mar;(276):1-8
pubmed: 28282020
Am J Hypertens. 2021 May 22;34(5):463-466
pubmed: 33245323
N Engl J Med. 2008 Mar 6;358(10):1037-52
pubmed: 18322285
Prog Cardiovasc Dis. 2017 Jun - Jul;60(1):45-55
pubmed: 28365296
J Am Geriatr Soc. 2017 Mar;65(3):504-510
pubmed: 28024086
Eur J Cancer Prev. 2001 Dec;10(6):489-99
pubmed: 11916347
Br J Sports Med. 2009 Jan;43(1):49-51
pubmed: 18971244
Br J Sports Med. 2019 Nov;53(22):1405-1411
pubmed: 30890520
Am J Cardiol. 2001 Dec 20;88(12A):9N-13N
pubmed: 11788124
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
J Health Popul Nutr. 2012 Mar;30(1):66-72
pubmed: 22524121
Trends Cardiovasc Med. 2016 Apr;26(3):232-40
pubmed: 26187713
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Med Sci Sports Exerc. 2002 Apr;34(4):592-5
pubmed: 11932565
Sports Med. 2001 Feb;31(2):101-14
pubmed: 11227978
Epidemiology. 2002 Sep;13(5):561-8
pubmed: 12192226
Br J Sports Med. 2015 Apr;49(7):434-40
pubmed: 25568330
Am J Epidemiol. 2002 Nov 1;156(9):832-41
pubmed: 12397001
Mayo Clin Proc. 2015 Nov;90(11):1541-52
pubmed: 26362561
Eur Heart J. 2015 Jun 14;36(23):1445-53
pubmed: 25839670
Public Health Nutr. 2011 May;14(5):835-45
pubmed: 21299917
Br J Sports Med. 2020 Oct;54(20):1195-1201
pubmed: 31406017
Scand J Public Health. 2002;30(2):103-12
pubmed: 12028859
Sci Rep. 2020 Dec 18;10(1):22287
pubmed: 33339835
BMC Public Health. 2020 Feb 21;20(1):261
pubmed: 32085709
Eur J Epidemiol. 2011 Feb;26(2):91-9
pubmed: 21153912
Eur J Prev Cardiol. 2018 Nov;25(17):1864-1872
pubmed: 30157685
Eur J Clin Nutr. 2009 Dec;63(12):1448-51
pubmed: 19639000
Br J Sports Med. 2017 May;51(10):812-817
pubmed: 27895075
J Atr Fibrillation. 2019 Oct 31;12(3):2167
pubmed: 32435330
Front Cardiovasc Med. 2020 Sep 25;7:585692
pubmed: 33102537
J Hypertens. 2017 Jan;35(1):10-17
pubmed: 27906836

Auteurs

Sara Bergwall (S)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. sara.bergwall@med.lu.se.

Stefan Acosta (S)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Vascular Centre, Department of Cardio-Thoracic and Vascular Surgery, Skåne University Hospital Malmö, Malmö, Sweden.

Stina Ramne (S)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Pascal Mutie (P)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Emily Sonestedt (E)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH